Medipharm Labs Corp (LABS)

Currency in CAD
0.08
-0.01(-6.25%)
Closed·

LABS Earnings

Latest Release
Aug 13, 2026
EPS / Forecast
-- / -0.00
Revenue / Forecast
9.98M / 8.93M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/060.000/-0.0039.98M/8.93M+100%+11.76%Free Sign Up
2026/030.000/--8.96M/------Free Sign Up
2025/120.000/-0.00214.06M/13.29M+100%+5.79%Free Sign Up
2025/09-0.010/-0.00111.45M/11.86M-900%-3.46%Free Sign Up
2025/06-0.010/-0.00311.81M/11.01M-222.58%+7.27%Free Sign Up
2025/030.000/-0.00310.81M/11.40M+100%-5.18%Free Sign Up
2024/12-0.004/-0.00215.29M/13.35M-147.06%+14.53%Free Sign Up
2024/09-0.007/-0.0039.80M/12.25M-109.38%-20%Free Sign Up
2024/06-0.010/-0.00810.35M/10.26M-26.58%+0.88%Free Sign Up
2024/03-0.010/-0.0109.77M/9.77M0%0%Free Sign Up

All numbers in CAD

Medipharm Labs Corp Earnings Call Summary for Q2/2026

  • MediPharm Labs returned to profitability in Q2 2026, posting first positive net income since 2019 with revenue up 11% to CAD 10.0M.
  • Adjusted EBITDA reached CAD 0.9M for second consecutive positive quarter; gross margin hit 43%, highest in recent periods.
  • International medical cannabis drove growth at CAD 5.8M, with Germany revenue surging 45% sequentially and 33% year-over-year.
  • Company expects continued international expansion with Brazil shipments in H2 2026; LiBBY dementia study met all primary endpoints.
  • Stock fell 6.25% to $0.08 despite results; Canadian medical revenue declined to CAD 2.3M due to Veterans Affairs reimbursement cuts.
Last Updated: 2026-08-13, 10:56 a/m
Read Full Transcript

FAQ

What Is Medipharm's Earnings Per Share (TTM)?

The Medipharm EPS (TTM) is -0.02.

When Is The Next Medipharm Earnings Date?

Medipharm will release its next earnings report on Aug 13, 2026.

What Is Medipharm’s Revenue Forecasts For Upcoming Quarters?

Medipharm’s revenue forecast is 10.18M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.